Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Sep;3(5):563–566. doi: 10.1128/cdli.3.5.563-566.1996

Comparison of two 2,3-diacyl trehalose antigens from Mycobacterium tuberculosis and Mycobacterium fortuitum for serology in tuberculosis patients.

M T Tórtola 1, M A Lanéelle 1, N Martín-Casabona 1
PMCID: PMC170406  PMID: 8877135

Abstract

Immunoglobulin G antibodies against two 2,3-diacyl trehalose (DAT) antigens from Mycobacterium tuberculosis (DATT) and Mycobacterium fortuitum (DATF) were studied by enzyme-linked immunosorbent assay of 356 serum samples. The sera were obtained from non-tuberculosis-infected individuals (282 serum samples) and tuberculosis patients (74 serum samples). Non-tuberculosis-infected individuals were healthy people (120 serum samples; positive purified-protein-derivative skin test, 60 patients; negative purified-protein-derivative skin test, 60 patients) patients with nontuberculosis lung disease (59 serum samples), contacts of sputum-smear-positive tuberculosis patients (57 serum samples), and human immunodeficiency virus-infected patients with nontuberculosis lung disease (46 serum samples). Of the 74 patients with tuberculosis, 14 were human immunodeficiency virus infected. The sensitivity of the method using DATT was 44.5%, and that with DATF was 48.6%. The specificities with both antigens were 99.1%. There were no significant differences between the mean values for both antigens (P = 0.2815). We therefore concluded that both antigens were interchangeable. As M. fortuitum, a fast-growing mycobacterium, could be a good source of antigen DAT, these results deserve consideration in the serology of tuberculosis.

Full Text

The Full Text of this article is available as a PDF (178.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariza M. A., Martín-Luengo F., Valero-Guillén P. L. A family of diacyltrehaloses isolated from Mycobacterium fortuitum. Microbiology. 1994 Aug;140(Pt 8):1989–1994. doi: 10.1099/13500872-140-8-1989. [DOI] [PubMed] [Google Scholar]
  2. Ariza M. A., Valero-Guillén P. L. Delineation of molecular species of a family of diacyltrehaloses from Mycobacterium fortuitum by mass spectrometry. FEMS Microbiol Lett. 1994 Jun 15;119(3):279–282. doi: 10.1111/j.1574-6968.1994.tb06901.x. [DOI] [PubMed] [Google Scholar]
  3. Baer H. H. The structure of an antigenic glycolipid (SL-IV) from Mycobacterium tuberculosis. Carbohydr Res. 1993 Feb 24;240:1–22. doi: 10.1016/0008-6215(93)84167-5. [DOI] [PubMed] [Google Scholar]
  4. Baer H. H., Wu X. Synthesis of alpha,alpha-trehalose 2,3- and 2,3'-diesters with palmitic and stearic acid: potential immunoreactants for the serodiagnosis of tuberculosis. Carbohydr Res. 1993 Jan 15;238:215–230. doi: 10.1016/0008-6215(93)87014-j. [DOI] [PubMed] [Google Scholar]
  5. Berlie H. C., Petit J. C., David H. L. Use of the SL-IV and the PGL-Tb1 glycolipid antigens in ELISA for the diagnosis of tuberculosis in AIDS patients. Zentralbl Bakteriol. 1991 Aug;275(3):351–357. doi: 10.1016/s0934-8840(11)80299-9. [DOI] [PubMed] [Google Scholar]
  6. Besra G. S., Bolton R. C., McNeil M. R., Ridell M., Simpson K. E., Glushka J., van Halbeek H., Brennan P. J., Minnikin D. E. Structural elucidation of a novel family of acyltrehaloses from Mycobacterium tuberculosis. Biochemistry. 1992 Oct 13;31(40):9832–9837. doi: 10.1021/bi00155a040. [DOI] [PubMed] [Google Scholar]
  7. Cruaud P., Yamashita J. T., Casabona N. M., Papa F., David H. L. Evaluation of a novel 2,3-diacyl-trehalose-2'-sulphate (SL-IV) antigen for case finding and diagnosis of leprosy and tuberculosis. Res Microbiol. 1990 Jul-Aug;141(6):679–694. doi: 10.1016/0923-2508(90)90062-u. [DOI] [PubMed] [Google Scholar]
  8. Daffé M., Papa F., Laszlo A., David H. L. Glycolipids of recent clinical isolates of Mycobacterium tuberculosis: chemical characterization and immunoreactivity. J Gen Microbiol. 1989 Oct;135(10):2759–2766. doi: 10.1099/00221287-135-10-2759. [DOI] [PubMed] [Google Scholar]
  9. Daniel T. M., Janicki B. W. Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties. Microbiol Rev. 1978 Mar;42(1):84–113. doi: 10.1128/mr.42.1.84-113.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goren M. B. Immunoreactive substances of mycobacteria. Am Rev Respir Dis. 1982 Mar;125(3 Pt 2):50–69. doi: 10.1164/arrd.1982.125.3P2.50. [DOI] [PubMed] [Google Scholar]
  11. Lemassu A., Lanéelle M. A., Daffé M. Revised structure of a trehalose-containing immunoreactive glycolipid of Mycobacterium tuberculosis. FEMS Microbiol Lett. 1991 Mar 1;62(2-3):171–175. doi: 10.1016/0378-1097(91)90153-2. [DOI] [PubMed] [Google Scholar]
  12. Martin-Casabona N., Gonzalez Fuente T., Papa F., Rosselló Urgell J., Vidal Plá R., Codina Grau G., Ruiz Camps I. Time course of anti-SL-IV immunoglobulin G antibodies in patients with tuberculosis and tuberculosis-associated AIDS. J Clin Microbiol. 1992 May;30(5):1089–1093. doi: 10.1128/jcm.30.5.1089-1093.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Papa F., Cruaud P., David H. L. Antigenicity and specificity of selected glycolipid fractions from Mycobacterium tuberculosis. Res Microbiol. 1989 Oct;140(8):569–578. doi: 10.1016/0923-2508(89)90089-2. [DOI] [PubMed] [Google Scholar]
  14. Puzo G. The carbohydrate- and lipid-containing cell wall of mycobacteria, phenolic glycolipids: structure and immunological properties. Crit Rev Microbiol. 1990;17(4):305–327. doi: 10.3109/10408419009105730. [DOI] [PubMed] [Google Scholar]
  15. Ridell M., Wallerström G., Minnikin D. E., Bolton R. C., Magnusson M. A comparative serological study of antigenic glycolipids from Mycobacterium tuberculosis. Tuber Lung Dis. 1992 Apr;73(2):101–105. doi: 10.1016/0962-8479(92)90063-P. [DOI] [PubMed] [Google Scholar]
  16. Young D. B. Structure of mycobacterial antigens. Br Med Bull. 1988 Jul;44(3):562–583. doi: 10.1093/oxfordjournals.bmb.a072268. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES